EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Therapeutic Options for Pulmonary and Sleep Disorders in Mucopolysaccharidosis (MPS) Patients: A Narrative Review

Bimaje Akpa iD

Advances in Respiratory Medicine · 22.06.2026 · 94 (3) · 41

DOI: 10.3390/arm94030041 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 22.06.2026. Verfasst von Bimaje Akpa. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Mucopolysaccharidoses, Sleep Wake Disorders, Lung Diseases. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucopolysaccharidosis (MPS) are a group of inherited lysosomal storage genetic disorders that affect the body’s ability to break down glycosaminoglycans (GAGs) due to the deficiency of required enzymes. This leads to depositions of these GAGs in various tissues and organs resulting in multi-systemic manifestations including pulmonary and sleep related issues. In recent years, there have been significant advancements in therapeutic options and supportive management which have led to the overall improvement in respiratory care, culminating in improved quality of life for MPS patients. Management of pulmonary and sleep disorders in mucopolysaccharidosis requires a multidisciplinary approach due to the multi-systemic affectation of the genetic disorders. Therapeutic options such as enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT) have yielded varying success in mitigating respiratory complications. Emerging treatments such as gene therapies have shown exciting and promising results thus far. Supportive therapies such as airway clearance, regular vaccination and use of positive airway pressure devices are also essential. Pre-operative airway and anesthesia planning is critical to mitigate peri-operative and post-operative complications. Early diagnosis, close monitoring and a patient focused individualized approach are essential for respiratory optimization and overall improvement in clinical outcomes. This review article aims to discuss these advancements in a comprehensive format, making it accessible to medical providers who care for this subset of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucopolysaccharidosesSleep Wake DisordersLung DiseasesHumansEnzyme Replacement TherapyHematopoietic Stem Cell TransplantationGenetic TherapyQuality of Life

Stichwörter der Autor:innen

advances in treatmentmucopolysaccharidosispulmonary disorderssleep disorders

Autor:innen und Institutionen

  • Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

ORCID-Profile: Bimaje Akpa

Zitieren

APA

Akpa, B. (2026). Advances in Therapeutic Options for Pulmonary and Sleep Disorders in Mucopolysaccharidosis (MPS) Patients: A Narrative Review. Advances in Respiratory Medicine, 94(3), 41. https://doi.org/10.3390/arm94030041

Vancouver

Akpa B. Advances in Therapeutic Options for Pulmonary and Sleep Disorders in Mucopolysaccharidosis (MPS) Patients: A Narrative Review. Advances in Respiratory Medicine. 2026;94(3):41. doi:10.3390/arm94030041

BibTeX
@article{Akpa2026,
  author = {Akpa, Bimaje},
  title = {Advances in Therapeutic Options for Pulmonary and Sleep Disorders in Mucopolysaccharidosis (MPS) Patients: A Narrative Review},
  journal = {Advances in Respiratory Medicine},
  year = {2026},
  volume = {94},
  number = {3},
  pages = {41},
  doi = {10.3390/arm94030041}
}
Kostenlos starten →